Epigral Stock Sees Decline in Line with Chemical Sector, Rated 'Hold' by MarketsMOJO

Epigral, a midcap chemical company, saw a decline of -5.37% in its stock price on October 22, 2024. This drop was in line with the overall performance of the chemical sector, which fell by -2.53%. The stock has been on a downward trend for the past two days, with a consecutive fall of -8.1% in returns during this period.

According to MarketsMOJO, a leading financial analysis platform, the stock of Epigral is currently rated as 'Hold'. It has also been identified as a part of the Hidden Turnaround category on MarketsMOJO since April 22, 2024.

On October 22, the stock touched an intraday low of Rs 2033.9, which is a decline of -4.96% from its previous closing price. However, the stock is still performing better than the chemical sector as a whole, with a -2.34% underperformance for the day.

In terms of moving averages, Epigral's stock is currently higher than its 100-day and 200-day moving averages. However, it is lower than its 5-day, 20-day, and 50-day moving averages. This indicates a mixed trend for the stock in the short term.

Compared to the overall market performance, Epigral's stock has underperformed the Sensex by -5.50% in the past day and has outperformed it by 1.74% in the past month. This suggests that the stock may have potential for growth in the long term.

Overall, Epigral's stock has seen a decline in its price on October 22, but it is still performing better than the chemical sector as a whole. With a 'Hold' rating from MarketsMOJO and a potential for long-term growth, investors may want to keep an eye on this midcap chemical company.